 |
市場調查報告書
商品編碼
1084760
冷凍乾燥藥的市場規模、佔有率、趨勢、預測 (2022年～2028年):各藥物類別、適應症、包裝類型、地區Lyophilized Drugs Market, by Drug Class, by Indication, by Packaging Type, and by region - Size, Share, Trends, and Forecast, 2022 - 2028 |
||||||
價格
簡介目錄
感染疾病的流行增加，有助於全球冷凍乾燥藥市場成長。還有製造商積極擴張冷凍乾燥劑的大規模製造設備，對該市場的成長也有貢獻。
本報告提供全球冷凍乾燥藥的市場調查，市場定義和概要，市場成長的各種影響因素分析，法律制度，技術趨勢，市場規模的變化、預測，各種區分、各地區/主要國家的明細，競爭環境，主要企業簡介等彙整資訊。
目錄
第1章 調查目的、前提條件
第2章 市場概要
第3章 市場動態、法律規章、趨勢分析
- 市場動態
- 促進因素
- 阻礙因素
- 市場機會
- 影響分析
- 市場趨勢
- 主要的展開
- 技術的進步
- 歷史概要
- M&A
- 法規情境
- 波特分析
- PEST分析
第4章 全球冷凍乾燥藥市場:各類藥物
- 抗感染藥
- 抗腫瘤劑
- 利尿劑
- 質子幫浦抑制劑
- 麻醉劑
- 抗凝固劑
- NSAID
- 其他
第5章 全球冷凍乾燥藥市場:各適應症
- 感染疾病
- 自體免疫疾病
- 腸胃疾病
- 癌症
- 其他
第6章 全球冷凍乾燥藥市場:各包裝形式
- 管瓶
- 注射器
- 濾芯
第7章 全球冷凍乾燥藥市場:各地區
- 北美
- 歐洲
- 亞太地區
- 南美
- 中東
- 非洲
第8章 競爭情形
- 熱圖分析
- 企業簡介
- Sanofi SA
- Merck &Co., Inc.
- Fresenius Kabi USA, LLC.
- Ciron Drugs &Pharmaceuticals Pvt Ltd.
- GlaxoSmithKline plc.
- Mylan NV.
- Pfizer, Inc.
- Amneal Pharmaceuticals LLC
- Otsuka Holdings Co., Ltd.(Otsuka Pharmaceutical Co., Ltd.)
- BTG Plc.
- 分析師的見解
第9章 Section
簡介目錄
Product Code: CMI2930
Lyophilization or freeze drying is the process, in which the water content in the drug sample is frozen, followed by its removal from the sample. In the process of lyophilization, the frozen water content changes directly from solid to vapor without passing through a liquid phase. The process includes three steps: Freezing, primary drying (sublimation), and secondary drying (desorption). Pharmaceutical products that undergo lyophilization process include bulk pharmaceutical/biopharmaceutical ingredient (API), protein, collagen, peptide, oligonucleotide, enzymes, and mAbs.
Market Dynamics
Lyophilized drugs are majorly used to treat infectious diseases and autoimmune diseases. Thus, increasing prevalence of infectious diseases is expected to aid in growth of the global lyophilized drugs market. For instance, according to The Lancet Infectious Diseases (report) published in 2021, fungal infection affects over a billion people worldwide, resulting in around 11.5 million life-threatening infections and over 1.5 million deaths, annually. The number of lyophilized drugs such as Amphotericin B (Mycoflu), Vonfung NDD (voriconazole,) and other antifungal lyophilized drugs are available in market for treating fungal infections.
Lyophilized drug manufacturers are looking forward to expand their facilities to produce lyophilized drugs on large scale, which in turn contributing to growth of the global lyophilized drugs market. For instance, on January 2021, AB Technologies (AB) announced investment of US$ 10.5 million to build a new 23,000-square-foot manufacturing facility at its site in Bloomington, Indiana. The new facility will include manufacturing area for formulating, filling, lyophilizing, and packaging drugs for early-phase clinical trial studies. Moreover, AB Technologies (AB) added aseptic filling and lyophilizer loading systems into the new facility.
Major pharmaceutical manufacturers are engaged in the development and launching of innovative lyophilized drugs, which is expected to drive the global lyophilized drugs market growth. For instance, in November 2018, Xellia Pharmaceuticals launched Vancomycin Hydrochloride for Injection, USP within the U.S. market. Vancomycin Hydrochloride for Injection is lyophilized powder to treat or prevent infections that are caused by bacteria
Key features of the study:
- This report provides in-depth analysis of the global lyophilized drugs market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global lyophilized drugs market based on the following parameters - company overview, financial performance, Technology portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future technology launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global lyophilized drugs market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global Lyophilized Drugs Market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Lyophilized Drugs Market, By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- Global Lyophilized Drugs Market, By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- Global Lyophilized Drugs Market, By Packaging Type:
- Vial
- Injection
- Cartridge
- Global Lyophilized Drugs Market, By Region:
- North America
- By Country:
- U.S.
- Canada
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- Middle East
- By Country/Region:
- GCC
- Israel
- Rest of Middle East
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Drug Class:
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- By Indication:
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Cancer
- Others
- By Packaging Type:
- Vial
- Injection
- Cartridge
- North America
- Company Profiles
- Sanofi S.A *
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co., Inc.
- Fresenius Kabi USA, LLC.
- Ciron Drugs & Pharmaceuticals Pvt Ltd.
- GlaxoSmithKline plc.
- Mylan NV.
- Pfizer, Inc.
- Amneal Pharmaceuticals LLC
- Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
- BTG Plc.
- Sanofi S.A *
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Indication
- Market Snippet, By Packaging Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Historical Overview
- Merger and Acquisition
- Regulatory Scenario
- PORTER'S Five Forces
- PEST Analysis
4. Global Lyophilized Drugs Market, By Drug Class, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Antineoplastic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Proton Pump Inhibitor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Anesthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Anticoagulant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- NSAID's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Lyophilized Drugs Market, By Indication, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Autoimmune Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Gastrointestinal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Lyophilized Drugs Market, By Packaging Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Vials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cartridge
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Lyophilized Drugs Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Packaging Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- Northern Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Sanofi S.A.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co., Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Fresenius Kabi USA, LLC.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ciron Drugs & Pharmaceuticals Pvt Ltd.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan NV.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Amneal Pharmaceuticals LLC
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Otsuka Holdings Co., Ltd. (Otsuka Pharmaceutical Co., Ltd.)
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BTG Plc.
- Company Overview
- Technology Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About us and Sales Contact
